Loading resource…

Institute of Cardiovascular Science, University College London; Department of Epidemiology, Im
Hypertrophic cardiomyopathy (HCM) affects 1 in 500 individuals globally and is associated with various clinical manifestations, including diastolic dysfunction and sudden cardiac death. The review highlights important updates in clinical guidelines, current gaps in knowledge, and challenges in implementing recommendations. It also discusses advances in genetics, imaging, and molecular research that may influence future diagnosis and therapy for HCM.
No account needed